Effect of valsartan on quality of life when added to usual therapy for heart failure: results from the Valsartan Heart Failure Trial.

[1]  J. Cohn,et al.  Effects of Valsartan on Circulating Brain Natriuretic Peptide and Norepinephrine in Symptomatic Chronic Heart Failure: The Valsartan Heart Failure Trial (Val-HeFT) , 2002, Circulation.

[2]  P. Vandervoort,et al.  Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. , 2002, Journal of the American College of Cardiology.

[3]  J. Cohn,et al.  Effect of valsartan on time-adjusted and hospitalization frequency rate in the valsartan heart failure trial , 2002 .

[4]  J. Cohn,et al.  A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. , 2001, The New England journal of medicine.

[5]  L. Stevenson,et al.  Preferences for quality of life or survival expressed by patients with heart failure. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  M. Rohrbaugh,et al.  Prognostic importance of marital quality for survival of congestive heart failure. , 2001, The American journal of cardiology.

[7]  S. Al-Kaade,et al.  Health-related quality of life measurement in heart failure: challenges for the new millennium. , 2001, Journal of cardiac failure.

[8]  I J Higginson,et al.  Using quality of life measures in the clinical setting , 2001, BMJ : British Medical Journal.

[9]  P. Ganz,et al.  Quality of life in patients with heart failure: do gender differences exist? , 2001, Heart & lung : the journal of critical care.

[10]  J. Cohn,et al.  Baseline demographics of the Valsartan Heart Failure Trial , 2000, European journal of heart failure.

[11]  J. Cohn,et al.  Effect of the Angiotensin Receptor Blocker Valsartan on Morbidity and Mortality in Heart Failure: the Valsartan Heart Failure Trial (Val-HeFT) , 2000 .

[12]  R. Hershberger,et al.  Comparative responsiveness of Short-Form 12 and Minnesota Living With Heart Failure Questionnaire in patients with heart failure. , 2000, Journal of cardiac failure.

[13]  G. Albrecht,et al.  The disability paradox: high quality of life against all odds. , 1999, Social science & medicine.

[14]  E. Bru,et al.  Functional Status and Depression among Men and Women with Congestive Heart Failure , 1998, International journal of psychiatry in medicine.

[15]  S. Yusuf,et al.  Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. , 1996, The American journal of cardiology.

[16]  J. Cohn,et al.  Cardiac failure: a revised paradigm. , 1995, Journal of cardiac failure.

[17]  T. Rector,et al.  Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. , 1995, Journal of cardiac failure.

[18]  J. Cohn,et al.  Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. , 1993, The American journal of cardiology.

[19]  J. Cohn,et al.  Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. , 1992, American heart journal.